Ayari Kitayama

Long-term intravenous administration of activated autologous lymphocytes for cancer patients does not induce antinuclear antibody and rheumatoid factor.

K. Ogawa, Tomohiro Yamaguchi, N. Shimizu, 2004, Anticancer research.